The European Commission has approved Kisunla, a treatment for mild cognitive impairments, including dementia in the early stages of Alzheimer's disease. Although the drug, based on the molecule donanemab, has shown promising results in clinical trials, controversy remains regarding its actual benefits and the risks of serious side effects. The authorization is conditional on its administration only to patients without genetic mutations that could increase the risks. EU member states have the freedom to decide on reimbursement, and other countries, such as the United Kingdom, have adopted a similar approach.
Sources
Uniunea Europeană autorizează Kisunla, un tratament al Eli Lilly controversat împotriva maladiei Alzheimer. În afară de beneficii reale modeste, are efecte secundare grave, uneori mortale, şi anume hemoragii şi edeme cerebrale
UE a aprobat un nou medicament pentru Alzheimer
UE a aprobat un nou tratament controversat împotriva Alzheimer
Noi tratamente împotriva Alzheimer: UE a autorizat un medicament promițător, dar cu efecte secundare grave posibile
Noi tratamente împotriva Alzheimer: UE autorizează medicamentul Kisunla, produs de Eli Lilly
Noi tratamente împotriva Alzheimer: UE autorizează medicamentul Kisunla, produs de Eli Lilly
O nouă speranță pentru pacienții cu ALZHEIMER. Comisia Europeană aprobă primul tratament care poate încetini evoluția bolii
Comisia Europeană a autorizat comercializarea unui medicament pentru tratarea bolii Alzheimer în stadii incipiente
Latest News
08:41
Romania is taking emergency measures to ensure the necessary water supply for the Cernavodă Power Plant, in the context of the decreasing flow of the Danube.
08:28
Prince Harry, Elton John and other celebrities have been ordered by the court to pay millions of pounds in the lawsuit against "The Daily Mail".
08:19
American planes are flying over the Taiwan Strait, confirming the commitment of the USA
07:46
Fire at Fundeni Clinical Institute: 37 patients evacuated
07:33
The Pentagon fires the editor-in-chief of the military newspaper "Stars and Stripes" for insubordination.
See more news